Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Metformin for Metabolic Abnormalities in Clozapine-Treated Schizophrenia
NCT02751307Phase 4Completed
- Sponsor
- Taipei Medical University WanFang Hospital
- Start
- May 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of metformin in metabolic syndrome, sponsored by Taipei Medical University WanFang Hospital. Started May 2013; status: completed.
02
Drugs
metformin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT02751307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751307.